Loading...
Targeting BRAF Mutant Colorectal Cancer: Progress in Combination Strategies
BRAF mutations in colorectal cancer portend a poor prognosis, with first-line treatment often involving triplet or quadruplet chemotherapy, and single agent targeted therapy with BRAF inhibitors failing to demonstrate clinical activity. Blockade of multiple critical nodes along the MAPK and other pa...
Na minha lista:
| Udgivet i: | Cancer Discov |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5458523/ https://ncbi.nlm.nih.gov/pubmed/28576843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0087 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|